VENTXP6

Across TCGA pan-cancer cohorts, VENTXP6 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated VENTXP6 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher VENTXP6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VENTXP6 expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.

LIHC, ACC, and OV are the cancer types where VENTXP6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	II,III,IV	0.232	0.457	.001	45	view →
ACC	OS	Tertile	All	0.513	0.916	<.001	42	view →
OV	DFS	Quartile	All	0.470	0.357	.003	42	view →
UVM	OS	Tertile	II,III,IV	0.348	0.682	.007	36	view →
SKCM	DFS	Tertile	All	0.810	0.715	.007	30	view →
CHOL	OS	Tertile	II,III,IV	0.934	0.356	.008	27	view →
LUAD	OS	Tertile	All	0.486	0.287	.013	20	view →
DLBC	DFS	Tertile	IV	0.120	0.683	.001	18	view →
READ	DFS	Tertile	IV	0.262	0.634	.016	18	view →
BRCA	DFS	Tertile	IV	0.892	0.434	.022	12	view →
GBM	OS	Tertile	All	0.270	0.440	.006	9	view →
THYM	DFS	Tertile	IV	0.407	1.000	.026	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

VENTXP6–LIHC (DFS)

Open the LIHC breakdown →